Oncostellae Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Investors
-
12
Oncostellae General Information
Description
Developer of molecule drugs designed to focus on the treatment of autoimmune diseases. The company's drugs are created with innovative scaffolds that modulate clinically validated therapeutic targets in oncology, inflammatory, and autoimmune diseases, enabling hospitals to provide treatment for cancer and other serious diseases.
Contact Information
Website
www.oncostellae.comCorporate Office
- Edificio Feuga
- D.5 Rua Lope Gomez De Marzoa, S/N
- 15705 Santiago de Compostela
- Spain
Corporate Office
- Edificio Feuga
- D.5 Rua Lope Gomez De Marzoa, S/N
- 15705 Santiago de Compostela
- Spain
Oncostellae Timeline
Oncostellae Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 01-Feb-2024 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 01-Jun-2023 | Completed | Generating Revenue | |||
| 9. Equity Crowdfunding | 23-Nov-2022 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 23-Nov-2022 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 23-Jun-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series 2) | 22-Dec-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 17-May-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 17-Apr-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 26-Jul-2017 | $2.12M | $2.4M | Completed | Startup | |
| 2. Seed Round | 12-Feb-2016 | $274K | $274K | Completed | Startup |
Oncostellae Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | 8,140 | $10.874565 | $247.15 | $247.15 | 1x | $247.15 | 19.6% | |
| Ordinary Shares | 1,408 | $10.874565 | $193.09 | $193.09 | 1x | $193.09 | 3.39% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Oncostellae Patents
Oncostellae Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11453660-B2 | Androgen receptor and glucocorticoid receptor modulators | Active | 06-Nov-2017 | ||
| CA-3079804-A1 | Dihydropyridin derivatives as androgen receptor and glucocorticoid receptor modulators | Pending | 06-Nov-2017 | ||
| AU-2018361566-A1 | New analogs as androgen receptor and glucocorticoid receptor modulators | Active | 06-Nov-2017 | ||
| AU-2018361566-B2 | New analogs as androgen receptor and glucocorticoid receptor modulators | Active | 06-Nov-2017 | ||
| EP-3480201-A1 | New analogs as androgen receptor and glucocorticoid receptor modulators | Inactive | 06-Nov-2017 | C07D495/04 |
Oncostellae Signals
Oncostellae Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Enisa National Innovation Company | Lender/Debt Provider | Minority | ||
| Inicio - Ministerio de Ciencia, Innovación y Universidades | Government | Minority | ||
| Innvierte Economia Sostenible | Venture Capital | Minority | ||
| Ministerio de Economía, Industria y Competitividad | Government | Minority | ||
| Noso Capital | PE/Buyout | Minority |
Oncostellae FAQs
-
When was Oncostellae founded?
Oncostellae was founded in 2013.
-
Where is Oncostellae headquartered?
Oncostellae is headquartered in Santiago de Compostela, Spain.
-
What is the size of Oncostellae?
Oncostellae has 10 total employees.
-
What industry is Oncostellae in?
Oncostellae’s primary industry is Drug Discovery.
-
Is Oncostellae a private or public company?
Oncostellae is a Private company.
-
What is Oncostellae’s current revenue?
The current revenue for Oncostellae is .
-
How much funding has Oncostellae raised over time?
Oncostellae has raised $13.4M.
-
Who are Oncostellae’s investors?
Enisa National Innovation Company, Inicio - Ministerio de Ciencia, Innovación y Universidades, Innvierte Economia Sostenible, Ministerio de Economía, Industria y Competitividad, and Noso Capital are 5 of 12 investors who have invested in Oncostellae.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process